Triple-negative breast cancer (TNBC), in which the expression of estrogen receptor (ER), progesterone receptor and human epidermal growth factor receptor 2 are lacking, is a common and aggressive subtype of breast cancer with poor prognostic outcome and reduced short-term survival compared with other types of breast cancer1. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.